Ascorbic acid intake and oxalate synthesis

Urolithiasis

Volumn 44, Issue 4, 2016, Pages 289-297

  Knight, John ^a   Madduma Liyanage, Kumudu ^a   Mobley, James A ^b   Assimos, Dean G ^a   Holmes, Ross P ^a  

^a Hugh Kaul Human Genetics Building   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Ascorbate; Metabolism; Oxalate; Vitamin C

Indexed keywords

ASCORBIC ACID; OXALIC ACID; STABLE ISOTOPE; OXALIC ACID DERIVATIVE;

ABSORPTION; ASCORBIC ACID METABOLISM; CALCIUM OXALATE STONE; CIRCULATION; DIETARY INTAKE; HUMAN; HYPOXIA; INGESTION; NEPHROLITHIASIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SYNTHESIS; URINARY EXCRETION; DIET; METABOLISM; PHYSIOLOGY;

ASCORBIC ACID; DIET; HUMANS; OXALATES;

EID: 84961825637     PISSN: 21947228     EISSN: 21947236     Source Type: Journal    
DOI: 10.1007/s00240-016-0868-7     Document Type: Review

References (67)

1. Hellman L, Burns JJ (1958) Metabolism of l-ascorbic acid-1-C14 in man. J Biol Chem 230:923–930
2. Atkins GL, Dean BM, Griffin WJ, Watts RWE (1964) Quantitative aspects of ascorbic acid metabolism in man. J Biol Chem 239:2975–2980
3. Baker EM, Saari JC, Tolbert BM (1966) Ascorbic acid metabolism in man. Amer J Clin Nutr 19:371–378
4. Chalmers AH, Cowley DM (1985) Stability of ascorbate in urine: relevance to analyses for ascorbate and oxalate. Clin Chem 31:1703–1705
5. Mazzachi BC, Teubner JK, Ryall RL (1984) Factors affecting measurement of urinary oxalate. Clin Chem 30:1339–1343
6. Taylor EN, Stampfer MJ, Curhan GC (2004) Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol JASN 15:3225–3232
7. Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A (2013) Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med 173:386–388
8. Lawton JM, Conway LT, Crosson JT, Smith CL, Abraham PA (1985) Acute oxalate nephropathy after massive ascorbic acid administration. Arch Intern Med 145:950–951
9. Lamarche J, Nair R, Peguero A, Courville C (2011) Vitamin C-induced oxalate nephropathy. Int J Nephrol 2011:146927
10. Nasr SH, Kashtanova Y, Levchuk V, Markowitz GS (2006) Secondary oxalosis due to excess vitamin C intake. Kidney Int 70:1672
11. Mashour S, Turner JF Jr, Merrell R (2000) Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature. Chest 118:561–563
12. Alkhunaizi AM, Chan L (1996) Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. J Am Soc Nephrol: JASN 7:2320–2326
13. Robitaille L, Mamer OA, Miller WH Jr, Levine M, Assouline S, Melnychuk D, Rousseau C, Hoffer LJ (2009) Oxalic acid excretion after intravenous ascorbic acid administration. Metab Clin Exp 58:263–269
14. Taylor EN, Curhan GC (2008) Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol: CJASN 3:1453–1460
15. Halliwell B (2001) Vitamin C and genomic stability. Mutat Res 475:29–35
16. Nishikimi M, Yagi K (1991) Molecular basis for the deficiency in humans of gulonolactone oxidase, a key enzyme for ascorbic acid biosynthesis. Am J Clin Nutr 54:1203S–1208S
17. Grano A, De Tullio MC (2007) Ascorbic acid as a sensor of oxidative stress and a regulator of gene expression: the Yin and Yang of vitamin C. Med Hypotheses 69:953–954
18. Du J, Cullen JJ, Buettner GR (2012) Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta 1826:443–457
19. Linster CL, Van Schaftingen E (2007) Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J 274:1–22
20. Holmes RP, Goodman HO, Assimos DG (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270–276
21. Knight J, Assimos DG, Callahan MF, Holmes RP (2011) Metabolism of primed, constant infusions of [1,2-(13)C(2)] glycine and [1-(13)C(1)] phenylalanine to urinary oxalate. Metab Clin Exp 60:950–956
22. Knight J, Jiang J, Assimos DG, Holmes RP (2006) Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int 70:1929–1934
23. Holmes RP, Kennedy M (2000) Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int 57:1662–1667
24. 2] oxalate absorption test. J Urol 169:687–690
25. Fan X, Sokorai KJ (2011) Changes in quality, liking, and purchase intent of irradiated fresh-cut spinach during storage. J Food Sci 76:S363–S368
26. Jansson PJ, Jung HR, Lindqvist C, Nordstrom T (2004) Oxidative decomposition of vitamin C in drinking water. Free Radical Res 38:855–860
27. Burzle M, Suzuki Y, Ackermann D, Miyazaki H, Maeda N, Clemencon B, Burrier R, Hediger MA (2013) The sodium-dependent ascorbic acid transporter family SLC23. Mol Asp Med 34:436–454
28. Corpe CP, Eck P, Wang J, Al-Hasani H, Levine M (2013) Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8. J Biol Chem 288:9092–9101
29. Kallner A, Hartmann D, Hornig D (1977) On the absorption of ascorbic acid in man. Int J Vitam Nutr Res. Int Z fur Vitam und Ernahrungsforschung. J Int de Vitaminol et de Nutr 47:383–388
30. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazerev A, Graumlich JF, King J, Cantilena LR (1996) Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci 93:3704–3709
31. Bluck LJ, Izzard AP, Bates CJ (1996) Measurement of ascorbic acid kinetics in man using stable isotopes and gas chromatography/mass spectrometry. J Mass Spectrom: JMS 31:741–748
32. Kallner A, Hartmann D, Hornig D (1979) Steady-state turnover and body pool of ascorbic acid in man. Am J Clin Nutr 32:530–539
33. Omaye ST, Schaus EE, Kutnink MA, Hawkes WC (1987) Measurement of vitamin C in blood components by high-performance liquid chromatography. Implication in assessing vitamin C status. Ann New York Acad Sci 498:389–401
34. Levine M, Wang Y, Padayatty SJ, Morrow J (2001) A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 98:9842–9846
35. Baker PR, Cramer SD, Kennedy M, Assimos DG, Holmes RP (2004) Glycolate and glyoxylate metabolism in HepG2 cells. Amer J Physiol 287:C1359–C1365
36. Knight J, Holmes RP, Cramer SD, Takayama T, Salido E (2012) Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol. Renal Physiol 302:F688–F693
37. Corti A, Casini AF, Pompella A (2010) Cellular pathways for transport and efflux of ascorbate and dehydroascorbate. Arch Biochem Biophys 500:107–115
38. Rumsy SC, Levine M (1998) Absorption, transport, and disposition of ascorbic acid in humans. Nutr Biochem 9:116–130
39. Levine M, Padayatty SJ, Espey MG (2011) Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr 2:78–88
40. Stephenson CM, Levin RD, Spector T, Lis CG (2013) Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol 72:139–146
41. Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, Muley A, Asara JM, Paik J, Elemento O, Chen Z, Pappin DJ, Dow LE, Papadopoulos N, Gross SS, Cantley LC (2015) Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350:1391–1396
42. Park JB, Levine M (1996) Purification, cloning and expression of dehydroascorbic acid-reducing activity from human neutrophils: identification as glutaredoxin. Biochem J 315(Pt 3):931–938
43. Simpson GL, Ortwerth BJ (2000) The non-oxidative degradation of ascorbic acid at physiological conditions. Biochim Biophys Acta 1501:12–24
44. Nemet I, Monnier VM (2011) Vitamin C degradation products and pathways in the human lens. J Biol Chem 286:37128–37136
45. Gál I (1936) Estimation of ascorbic acid (vitamin C) by titration. Nature 138:799
46. Moeslinger T, Brunner M, Volf I, Spieckermann PG (1995) Spectrophotometric determination of ascorbic acid and dehydroascorbic acid. Clin Chem 41:1177–1181
47. Lee W, Roberts SM, Labbe RF (1997) Ascorbic acid determination with an automated enzymatic procedure. Clin Chem 43:154–157
48. Lykkesfeldt J (2007) Ascorbate and dehydroascorbic acid as reliable biomarkers of oxidative stress: analytical reproducibility and long-term stability of plasma samples subjected to acidic deproteinization. Cancer Epidemiol Biomark Prev 16:2513–2516
49. Chen Z, Chen B, Yao S (2006) High-performance liquid chromatography/electrospray ionization-mass spectrometry for simultaneous determination of taurine and 10 water-soluble vitamins in multivitamin tablets. Anal Chim Acta 569:169–175
50. Shui G, Leong LP (2004) Analysis of polyphenolic antioxidants in star fruit using liquid chromatography and mass spectrometry. J Chromatogr A 1022:67–75
51. Szultka M, Buszewska-Forajta M, Kaliszan R, Buszewski B (2014) Determination of ascorbic acid and its degradation products by high-performance liquid chromatography-triple quadrupole mass spectrometry. Electrophoresis 35:585–592
52. Fenoll J, Martinez A, Hellin P, Flores P (2011) Simultaneous determination of ascorbic and dehydroascorbic acids in vegetables and fruits by liquid chromatography with tandem mass spectrometry. Food Chem 127:340–344
53. Wang H, Jiang J, Hu P (2006) Determination of l-threonate in human plasma and urine by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr. B Anal Technol Biomed Life Sci 834:155–162
54. Deutsch JC (1998) Spontaneous hydrolysis and dehydration of dehydroascorbic acid in aqueous solution. Anal Biochem 260:223–229
55. Traxer O, Huet B, Poindexter J, Pak CY, Pearle MS (2003) Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170:397–401
56. Baxmann AC, De OGMC, Heilberg IP (2003) Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int 63:1066–1071
57. Khan SR (2012) Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urol Res 40:95–112
58. Ribeiro DO, Pinto DC, Lima LM, Volpato NM, Cabral LM, de Sousa VP (2011) Chemical stability study of vitamins thiamine, riboflavin, pyridoxine and ascorbic acid in parenteral nutrition for neonatal use. Nutr J 10:47
59. Holmes RP, Goodman HO, Assimos DG (1995) Dietary oxalate and its intestinal absorption. Scan Microsc 9:1109–1120
60. Pena de la Vega L, Lieske JC, Milliner D, Gonyea J, Kelly DG (2004) Urinary oxalate excretion increases in home parenteral nutrition patients on a higher intravenous ascorbic acid dose. JPEN J Parenter Enter Nutr 28:435–438
61. Pauling L (1970) Evolution and the need for ascorbic acid. Proc Natl Acad Sci USA 67:1643–1648
62. Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M (2010) Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One 5:e11414
63. Cossey LN, Rahim F, Larsen CP (2013) Oxalate nephropathy and intravenous vitamin C. Am J Kidney Dis 61:1032–1035
64. Rathi S, Kern W, Lau K (2007) Vitamin C-induced hyperoxaluria causing reversible tubulointerstitial nephritis and chronic renal failure: a case report. J Med Case Rep 1:155
65. Wong K, Thomson C, Bailey RR, McDiarmid S, Gardner J (1994) Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med 24:410–411
66. McHugh GJ, Graber ML, Freebairn RC (2008) Fatal vitamin C-associated acute renal failure. Anaesth Intensive Care 36:585–588
67. Gurm H, Sheta MA, Nivera N, Tunkel A (2012) Vitamin C-induced oxalate nephropathy: a case report. J Community Hosp Intern Med Perspect 2:17718